{"id":3426,"date":"2026-02-09T20:07:37","date_gmt":"2026-02-09T11:07:37","guid":{"rendered":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/?p=3426"},"modified":"2026-02-09T20:07:37","modified_gmt":"2026-02-09T11:07:37","slug":"jrr-3%e3%81%a7%e8%a3%bd%e9%80%a0%e3%81%95%e3%82%8c%e3%81%9f%e5%9b%bd%e7%94%a3lu-177%e3%82%92%e6%b4%bb%e7%94%a8%e3%81%97%e3%81%9f%e3%80%81fap%e9%98%bb%e5%ae%b3%e5%89%a4%e6%a8%99%e8%ad%98%e8%96%ac","status":"publish","type":"post","link":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/2026-02-09-3426\/","title":{"rendered":"JRR-3\u3067\u88fd\u9020\u3055\u308c\u305f\u56fd\u7523Lu-177\u3092\u6d3b\u7528\u3057\u305f\u3001FAP\u963b\u5bb3\u5264\u6a19\u8b58\u85ac\u5264\u306b\u3088\u308b\u653e\u5c04\u6027\u30ea\u30ac\u30f3\u30c9\u7642\u6cd5\u306e\u524d\u81e8\u5e8a\u7814\u7a76\u306b\u95a2\u3059\u308b\u8ad6\u6587\u304c\u3001Annals of Nuclear Medicine\u8a8c\u306b\u53d7\u7406\u3055\u308c\u307e\u3057\u305f\u3002"},"content":{"rendered":"<div class=\"entry\">\n<p>JRR-3\u3067\u88fd\u9020\u3055\u308c\u305f\u56fd\u7523Lu-177\u3092\u6d3b\u7528\u3057\u305f\u3001FAP\u963b\u5bb3\u5264\u6a19\u8b58\u85ac\u5264\u306b\u3088\u308b\u653e\u5c04\u6027\u30ea\u30ac\u30f3\u30c9\u7642\u6cd5\u306e\u524d\u81e8\u5e8a\u7814\u7a76\u306b\u95a2\u3059\u308b\u8ad6\u6587\u304c\u3001Annals of Nuclear Medicine\u8a8c\u306b\u53d7\u7406\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<ul>\n<li>Preclinical evaluation of novel <span style=\"color: #333333\"><sup>177<\/sup><\/span>Lu-labeled fibroblast activation protein inhibitor with albumin binder for radioligand therapy (Saito K, et al.)<\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>JRR-3\u3067\u88fd\u9020\u3055\u308c\u305f\u56fd\u7523Lu-177\u3092\u6d3b\u7528\u3057\u305f\u3001FAP\u963b\u5bb3\u5264\u6a19\u8b58\u85ac\u5264\u306b\u3088\u308b\u653e\u5c04\u6027\u30ea\u30ac\u30f3\u30c9\u7642\u6cd5\u306e\u524d\u81e8\u5e8a\u7814\u7a76\u306b\u95a2\u3059\u308b\u8ad6\u6587\u304c\u3001Annals of Nuclear Medicine\u8a8c\u306b\u53d7\u7406\u3055\u308c\u307e\u3057\u305f\u3002 Preclinical  [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-3426","post","type-post","status-publish","format-standard","hentry","category-info"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/posts\/3426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/comments?post=3426"}],"version-history":[{"count":2,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/posts\/3426\/revisions"}],"predecessor-version":[{"id":3428,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/posts\/3426\/revisions\/3428"}],"wp:attachment":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/media?parent=3426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/categories?post=3426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/tags?post=3426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}